Clinical Trials Directory

Trials / Conditions / Ascites

Ascites

108 registered clinical trials studyying Ascites14 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingVIATORR® TIPS Study Evaluating 6-10mm Diameters (VIATIPS)
NCT07390344
W.L.Gore & Associates
RecruitingApixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
NCT07521332
Asian Institute Of Medical SciencesPhase 4
RecruitingIntraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites
NCT07435701
Cancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 1 / Phase 2
RecruitingFree Fluid Detection With Telementored eFAST
NCT06594562
Oslo University HospitalN/A
RecruitingKinesio-Taping vs. Usual Care for Malignant Bowel Obstruction With Ascites
NCT07023042
National Taiwan University HospitalN/A
RecruitingDrug Sensitivity of Hydrothorax and Ascite Organoids from Breast Cancer
NCT06658080
Second Affiliated Hospital, School of Medicine, Zhejiang University
Not Yet RecruitingHigh Definition Profiling of Ovarian Cancer Ascites
NCT06553742
European Institute of Oncology
RecruitingPediatric Intravenous Contrast-Enhanced Ultrasound(CEUS) in China
NCT07113808
The Children's Hospital of Zhejiang University School of Medicine
CompletedPMCF Study of the CE-marked Drainova® ArgentiC Catheter
NCT06436807
ewimed GmbH
Enrolling By InvitationApplication of Bacterial DNA Quantitative Detection in Diagnosis of SBP in Cirrhosis: A Multi Center Diagnosti
NCT06995846
Beijing YouAn Hospital
UnknownThe INSIGHT Feasibility Study Ultrasound in the Intensive Care Unit: A Randomised Controlled Feasibility Trial
NCT05569798
King's College Hospital NHS TrustN/A
TerminatedEfficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (
NCT05900050
GenfitPhase 2
CompletedLung Point of Care Ultrasound to Guide Albumin Administration in Cirrhosis
NCT07072572
Centro Medico IssemymPhase 3
UnknownClinical Validation of Programmable Drain Fluid Regulator to Reduce Morbidity, Care Requirements, and Improve
NCT05734729
Changi General HospitalN/A
UnknownComparison of Crystalloid and Colloid I.V Fluid Therapy in Prevention of Paracentesis Induced Circulatory Dysf
NCT05220891
Shady Ashraf Kassem
UnknownPoint-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in C
NCT05700708
Post Graduate Institute of Medical Education and Research, Chandigarh
UnknownAllopurinol Versus Atorvastatin to Prevent Complications of Liver Cirrhosis
NCT05511766
Tanta UniversityPhase 2 / Phase 3
CompletedA Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney
NCT05309200
Ocelot Bio, IncPhase 2
UnknownUtility of 2- Octyl Cyanoacrylate (2-OCA)
NCT05278013
Methodist Health SystemN/A
CompletedEmpagliflozin in Diuretic Refractory Ascites
NCT05013502
Stanford UniversityPhase 1
Recruiting13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients.
NCT05025878
British Columbia Cancer Agency
TerminatedA Study for Evaluation of BIV201 to Reduce Ascites and Complications in Patients With Cirrhosis and Refractory
NCT04112199
BioVie Inc.Phase 2
CompletedInvestigating Signal Change in Malignant and Non-malignant Pleural Effusions and asCitic Fluid Using fTiR Anal
NCT04533854
Portsmouth Hospitals NHS Trust
CompletedComparative Study of Secondary Prophylaxis for SBP
NCT06827756
Tanta UniversityPhase 4
UnknownTIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites
NCT04640116
Sun Yat-sen UniversityN/A
CompletedThe BRAINFOOD Trial to Prevent Recurrent Hepatic Encephalopathy.
NCT04675775
University of MichiganN/A
CompletedNon-Pharmaceutical Intervention for Cirrhotic Cramps Reduction: The NICCles Trial
NCT04650295
University of MichiganN/A
UnknownRole Of Multi-detector Computed Tomography In Differentiation Between Different Types Of Ascites
NCT04550091
Assiut University
TerminatedComparison of "Roll-over' Technique With Standard Abdominal Paracentesis in Suspected Peritoneal Carcinomatosi
NCT04232384
Post Graduate Institute of Medical Education and Research, ChandigarhN/A
UnknownCell Block Immunohistochemistry in Effusion Cytology
NCT04279327
Assiut University
Active Not RecruitingComparing Ascites Relief In Two Standard Treatments: Large Volume Paracentesis Vs. Early Tips Using Viatorr Co
NCT04315571
University of California, Los AngelesN/A
CompletedPhase Ib of Recombinant Human Albumin Injection
NCT04701697
The First Hospital of Jilin UniversityPhase 1
CompletedDoes Point of Care Ultrasound Change Needle Insertion Location During Routine Bedside Paracentesis?
NCT04245553
Steven MontagueN/A
UnknownAlfapump® System in the Treatment of Refractory or Recurrent Ascites (POSEIDON Study)
NCT03973866
Sequana Medical N.V.N/A
CompletedSafety and Tolerance Study of Recombinant Human Albumin Injection in Healthy Subjects.
NCT04641364
The First Hospital of Jilin UniversityPhase 1
TerminatedA Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis
NCT03827200
Noorik Biopharmaceuticals AGPhase 2
RecruitingHigh Dose Albumin in Refractory Ascites
NCT05867602
Baylor College of MedicinePhase 2
RecruitingMedical-economic Evaluation of the Care of Refractory Ascites by Implantation of Alfapump® Device in Cirrhotic
NCT03506893
University Hospital, GrenobleN/A
CompletedTwo Strategies of Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Severe Cirrhotic Patients With A
NCT03069131
Centre Hospitalier Universitaire de BesanconPhase 3
CompletedTackling 30-day Readmissions in Patients With Cirrhosis: The SALTYFOOD Trial
NCT03493204
University of MichiganN/A
SuspendedPreoperative Ascites Drainage Versus Standard Care for Patients With Advanced Ovarian Cancer
NCT02742428
Gdynia Oncology CenterN/A
UnknownDiagnosis of Ascites in Infants and Children
NCT03341221
Assiut University
CompletedPoint-of-care Ultrasound in Finland
NCT03327688
Ossi HannulaN/A
UnknownEvaluation of Different Etiologies of Obscure Ascites
NCT03205748
Assiut University
RecruitingVICIS - Vienna Cirrhosis Study
NCT03267615
Medical University of Vienna
CompletedPeritoneal Dialysis Catheters for the Treatment of Refractory Ascites
NCT02975726
University of ManitobaN/A
UnknownLiquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid
NCT02891642
The First Affiliated Hospital with Nanjing Medical University
WithdrawnBedside Inoculation of Ascitic Fluid in Diagnostic Paracentesis
NCT02895919
Medical College of Wisconsin
UnknownThe Effect of Branched-chain Amino Acid on the Improvement of Serum Albumin Level in Cirrhotic Patients With A
NCT02755701
Soonchunhyang University HospitalPhase 4
UnknownThe Role of Intravenous Albumin Replacement During Abdominal Paracentesis in Patients With Malignancy Related
NCT02811406
National University Hospital, SingaporeN/A
CompletedValidation of Diagnostic Usefulness of the Random Urine Na/K Ratio for Replacement of 24hr Urine Na Excretion
NCT03263598
Jang Byoung Kuk
CompletedEvaluation of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With Decompensated Cirrhosis Wit
NCT02608658
St. Louis UniversityN/A
UnknownInternational Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
NCT03210298
Sabine Rhode
CompletedTo Study the Effect of Nonselective Beta Blockers in Advanced Stage Liver Disease With Ascites
NCT02649335
Post Graduate Institute of Medical Education and Research, ChandigarhPhase 3
TerminatedAZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites
NCT02417753
National Cancer Institute (NCI)Phase 2
CompletedA (M)Ulti-center, Prospective, (O)Pen Label, Uncontrolled Feasibility (S)Tudy to Assess the Safety and Effecti
NCT02400164
Sequana Medical N.V.N/A
RecruitingCirrhosis Registry of Hospitalized Patients
NCT04767945
F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica
CompletedLocal mEHT + TCM Versus Intraperitoneal Chemoinfusion in Treatment of Malignant Ascites: Phase II RCT
NCT02638051
Galenic Research Institute LtdPhase 2
UnknownComparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial Perito
NCT02120196
Sherief Abd-ElsalamPhase 3
CompletedMetabolic Effects of Furosemide +HSS in Refractory Ascites
NCT02821377
University of PalermoPhase 2
WithdrawnEplerenone Versus Spironolactone as Treatment of Ascites Due to Liver Cirrhosis; a Study of Efficacy and Side
NCT01801228
Emma NilssonPhase 2
UnknownBody Composition Analysis in Cirrhotic Undergoing Paracentesis
NCT02022150
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
CompletedIntestinal Decontamination With Rifaximin. The Inflammatory and Circulatory State in Patients With Cirrhosis
NCT01769040
Copenhagen University Hospital, HvidovrePhase 4
UnknownTolvaptan for Hyponatremia in Cirrhotic Patients With Ascites
NCT01716611
Konkuk University Medical CenterPhase 4
WithdrawnThe Effect of a Large-volume Paracentesis on Fatigue, Sleep, and Quality of Life in Cirrhosis
NCT01777971
NYU Langone Health
CompletedTolvaptan for Ascites in Cirrhotic Patients
NCT01292304
University of FloridaPhase 4
TerminatedVSL#3 and Spontaneous Bacterial Peritonitis
NCT01701297
Nottingham University Hospitals NHS TrustPhase 2
WithdrawnMechanism and the Effect of Midodrine on Portal Pressures in Patients With Cirrhosis
NCT01331785
The Cleveland ClinicN/A
CompletedHuman Albumin for the Treatment of Ascites in Patients With Hepatic Cirrhosis
NCT01288794
University of BolognaPhase 4
CompletedImproving Performance of Paracentesis in Medical Residency Training
NCT01403987
Boston Medical CenterN/A
UnknownConservative Treatment Versus Elective Repair of Umbilical Hernia in Patients With Ascites and Liver Cirrhosis
NCT01421550
Erasmus Medical CenterPhase 3
TerminatedEarly TIPS for Ascites Study
NCT01236339
W.L.Gore & AssociatesN/A
TerminatedDaptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis
NCT01455246
University of PadovaPhase 2 / Phase 3
CompletedPhase III Study of Tolvaptan Tablet to Treat Cirrhosis Ascites
NCT01349348
Otsuka Beijing Research InstitutePhase 3
CompletedImpact of Palliative Catheter Placement on the Quality of Life of Patients With Refractory Ascites
NCT01188746
Memorial Sloan Kettering Cancer CenterN/A
CompletedB-type Natriuretic Peptide in the Diagnosis of Heart Failure Related Ascites
NCT01150916
University of Sao PauloN/A
WithdrawnThe Influence of Paracentesis on Intra-abdominal Pressure and Kidney Function in Critically Ill Patients With
NCT01091233
University Hospital, Ghent
UnknownPortal Venous Hemodynamic Changes After Hepatectomy
NCT01073345
Heidelberg University
CompletedSafety and Performance of the Automated Fluid Shunt in Patients With Ascites and Diuretic Resistance
NCT01030185
NovaShunt AGPhase 2 / Phase 3
CompletedStudy on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal
NCT01059396
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauPhase 4
CompletedProcalcitonin in Cirrhotic Patients at High Risk for Sepsis
NCT01578226
Prof. Facchinetti Fabio
CompletedEffects of Long Term Albumin 20% Administration in Patients With Cirrhosis and Ascites.
NCT00968695
Instituto Grifols, S.A.Phase 4
CompletedThe Automated Fluid Shunt (AFS)in Chronic Congestive Heart Failure
NCT00907673
NovaShunt AGN/A
CompletedDose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascites
NCT01349335
Otsuka Beijing Research InstitutePhase 2
CompletedMultiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis
NCT01359462
Otsuka Beijing Research InstitutePhase 1
CompletedLong-term Follow-up of HALT-C Sustained Virological Responders
NCT00825877
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CompletedAbdominal Hernia in Cirrhotic Patients: Surgery or Conservative Treatment?
NCT02787772
University of Sao Paulo General HospitalN/A
WithdrawnEffect of Large Volume Paracentesis on Fatigue in Cirrhosis
NCT00603200
Weill Medical College of Cornell University
CompletedTelesonography Adaptation and Use to Improve the Standard of Patient Care Within a Dominican Community
NCT00591968
Edward Via Virginia College of Osteopathic MedicineN/A
TerminatedSodium Restriction in the Management of Cirrhotic Ascites
NCT00548366
University of Texas Southwestern Medical CenterPhase 4
SuspendedAcute Hemodynamics of Albumin Versus Normal Saline in Cirrhosis
NCT00511394
Govind Ballabh Pant HospitalN/A
TerminatedTrial of Sunitinib for Refractory Malignant Ascites
NCT00796861
Milton S. Hershey Medical CenterPhase 2
TerminatedSatavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver
NCT00366795
SanofiPhase 3
CompletedStudy of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symp
NCT00327444
SanofiPhase 2 / Phase 3
TerminatedSatavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver
NCT00359437
SanofiPhase 3
CompletedCirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS)
NCT00358878
SanofiPhase 3
UnknownPrevention of Decompensation in Liver Cirrhosis
NCT00239096
Odense University HospitalPhase 4
CompletedSpironolactone Versus Spironolactone Plus Furosemide (SVSSF)
NCT00741663
University of PadovaPhase 4
CompletedEffect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis
NCT00570622
Medical University of ViennaPhase 4
CompletedRenal and Cardiovascular Effects of Terlipressin in Patients With Cirrhosis and Ascites
NCT00115947
Hvidovre University HospitalPhase 2 / Phase 3
CompletedSatavaptan Dose-Ranging Study in the Prevention of Ascites
NCT00501384
SanofiPhase 2
CompletedSatavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites
NCT00501566
SanofiPhase 2
CompletedSatavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites
NCT00501722
SanofiPhase 2
CompletedVasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis
NCT00108355
US Department of Veterans AffairsPhase 4
CompletedTreatment With Octreotide in Patients With Lymphangioleiomyomatosis
NCT00005906
National Heart, Lung, and Blood Institute (NHLBI)Phase 2
CompletedNorth American Study for the Treatment of Refractory Ascites (NASTRA)
NCT00006166
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Phase 3
CompletedSpontaneous Bacterial Peritonitis: Incidence, Risk Factors and Outcome
NCT00490217
Tampere University
WithdrawnLipopolysaccharide Binding Protein and Development of Infectious Events in Cirrhotic Patients
NCT00760032
Florencia Vargas-VorackovaPhase 4